Reversible Cancer Therapeutics-related Cardiac Dysfunction Complicating Intra-cardiac Thrombi.

MLA

Tsujinaga, Shingo, et al. “Reversible Cancer Therapeutics-Related Cardiac Dysfunction Complicating Intra-Cardiac Thrombi.” Internal Medicine (Tokyo, Japan), vol. 59, no. 17, Sept. 2020, pp. 2155–60. EBSCOhost, https://doi.org/10.2169/internalmedicine.4792-20.

APA

Tsujinaga, S., Iwano, H., Oshino, T., Kadosaka, T., Mizuguchi, Y., Motoi, K., Chiba, Y., Koya, T., Temma, T., Kamiya, K., Fukushima, A., Koizumi, T., Sato, T., Takenaka, S., Tada, A., Ishizaka, S., Sarashina, M., Omote, K., Kamada, R., … Anzai, T. (2020). Reversible Cancer Therapeutics-related Cardiac Dysfunction Complicating Intra-cardiac Thrombi. Internal Medicine (Tokyo, Japan), 59(17), 2155–2160. https://doi.org/10.2169/internalmedicine.4792-20

Chicago

Tsujinaga, Shingo, Hiroyuki Iwano, Tomohiro Oshino, Takahide Kadosaka, Yoshifumi Mizuguchi, Ko Motoi, Yasuyuki Chiba, et al. 2020. “Reversible Cancer Therapeutics-Related Cardiac Dysfunction Complicating Intra-Cardiac Thrombi.” Internal Medicine (Tokyo, Japan) 59 (17): 2155–60. doi:10.2169/internalmedicine.4792-20.